Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Exercise | $24.8K | SEC | |
| ExerciseD | $0 | SEC | |
| Buy | $6.2K | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $24.8K | SEC | |
| AwardD | $0 | SEC | |
| Buy | $13.6K | SEC | |
| Buy | $14.2K | SEC | |
| Buy | $2.2K | SEC | |
| Buy | $10.3K | SEC | |
| Buy | $8.6K | SEC | |
| Buy | $14.5K | SEC | |
| Buy | $19.8K | SEC | |
| AwardD | $0 | SEC | |
| Award | $0 | SEC | |
| Buy | $4.3K | SEC | |
| Buy | $4.4K | SEC | |
| Buy | $9K | SEC | |
| Buy | $4.5K | SEC | |
| Buy | $5.1K | SEC | |
| Buy | $5.5K | SEC |